Glenmark Pharmaceuticals
GLENMARK.NS
#3173
Rank
$3.51 B
Marketcap
$12.43
Share price
-0.47%
Change (1 day)
97.30%
Change (1 year)

Revenue for Glenmark Pharmaceuticals (GLENMARK.NS)

Revenue in 2023 (TTM): $1.48 B

According to Glenmark Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $1.48 B. In 2022 the company made a revenue of $1.47 B a decrease over the years 2021 revenue that were of $1.62 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Glenmark Pharmaceuticals from 2012 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$1.48 B0.9%
2022$1.47 B-9.42%
2021$1.62 B13.15%
2020$1.43 B-1.47%
2019$1.45 B6.7%
2018$1.36 B-3.45%
2017$1.41 B8.6%
2016$1.30 B20.2%
2015$1.08 B2.64%
2014$1.05 B11.62%
2013$0.94 B6.65%
2012$0.88 B